Professor Moo Hyun Kim
Dong-a University Hospital, Busan (Korea (Republic of))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Pharmacodynamic comparison of optimal platelet reactivity by multiple platelet function tests in korean acute coronary syndrome patients with half-dose ticagrelor or prasugrel treatment
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Acute Coronary Syndromes ePosters
Social status and long-term events among acute myocardial infarction patients
Event: ESC Congress 2020
Topic: Environmental Aspects of Heart Disease
Session: Risk Factors and Prevention ePosters
De-escalation strategy with half-dose prasugrel or ticagrelor on pharmacodynamics and outcome in East Asians patients with acute coronary syndrome
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Acute Coronary Syndromes ePosters
State of the Art lecture 1 - Cancer risk after dual antiplatelet therapy.
Event: ESC Congress 2018
Topic: Cardiovascular Pharmacotherapy
Session: Antithrombotics and cancer: challenges in clinical practice
ESC 365 is supported by
